Market Overview:The human platelet lysate market is estimated to be valued at US$ 53.0 million in 2023 and is expected to exhibit a robust CAGR of 4.54% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Human platelet lysate is extensively used in regenerative therapies, particularly in stem cell research and tissue engineering...
The global human platelet lysate market size is anticipated to be worth US$ 56.1 million in 2024. Forecasts indicate that until 2034, the economy will expand gradually at a CAGR of 3.7%. By 2034, the market is projected to grow to US$ 80.4 million. Rising government funding for stem cell research mainly drives the market expansion for human platelet lysate.
In the...
The Human Platelet Lysate Market in 2023 is US$ 53 billion, and is expected to reach US$ 76.88 billion by 2031 at a CAGR of 4.76%.
FutureWise Research published a report that analyzes Human Platelet Lysate Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market...
Human platelet lysate (HPL) has garnered significant importance in the recent years as a substitute for animal serum in the fields of cell therapy and regenerative medicine. HPL contains growth factors obtained from platelets that are essential for cell growth. It is devoid of the risks of animal-origin pathogens and immunogenic reactions. HPL is used as a supplement in cell culture media...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian